Sarepta Therapeutics
SRPT
SRPT
407 hedge funds and large institutions have $11.9B invested in Sarepta Therapeutics in 2020 Q2 according to their latest regulatory filings, with 89 funds opening new positions, 128 increasing their positions, 130 reducing their positions, and 44 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
407
Holders Change
+43
Holders Change %
+11.81%
% of All Funds
8.37%
Holding in Top 10
6
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-25%
% of All Funds
0.12%
New
89
Increased
128
Reduced
130
Closed
44
Calls
$311M
Puts
$245M
Net Calls
+$66.1M
Net Calls Change
+$103M
Top Buyers
| 1 |
Capital Research Global Investors
Los Angeles,
California
|
+$133M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$91.9M |
| 3 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
+$81M |
| 4 |
BlackRock
New York
|
+$77.7M |
| 5 |
JPMorgan Chase & Co
New York
|
+$69.5M |
Top Sellers
| 1 |
Adage Capital Partners
Boston,
Massachusetts
|
-$148M |
| 2 |
CCM
Consonance Capital Management
New York
|
-$63.7M |
| 3 |
Invesco
Atlanta,
Georgia
|
-$61.5M |
| 4 |
O
OrbiMed
New York
|
-$55M |
| 5 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
-$52.1M |
